Democrats’ New Wave Leads Attack On Pharma At Drug Pricing Hearing

 
• By Sarah Karlin-Smith
  
Katie Porter at House oversight hearing on 30 September 2020
Rep. Katie Porter, R-CA, presses the case against Revlimid prices increases.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access